Evolving epNEC Care: From Default Regimens to Precision-Driven Strategies
Alexandria May, PharmD, BCPS
Chandrikha Chandrasekharan, MBBS
Redefining Cancer Care with Functional Precision Medicine
Matt Birnholz, MD
Jim Foote, MBA
Urinary and Circulating Tumor DNA in Muscle-Invasive Bladder Cancer: NIAGARA Data
Charles Turck, PharmD, BCPS, BCCCP
Petros Grivas, MD, PhD
ctDNA-Guided Adjuvant Atezolizumab in MIBC: IMvigor011 Insights
Guru P. Sonpavde, MD
ctDNA-Guided Bladder Preservation in Muscle-Invasive Bladder Cancer
Pooja Ghatalia, MD
Advancing Relapse Prediction in Pediatric AML Through Genomic MRD
Ryan Quigley
Amanda Winters, MD, PhD
Tracking Treatment Response: ctDNA Insights in MMR-p Colon Cancer
Brian P. McDonough, MD, FAAFP
Christopher T. Chen, MD
Tracking Early Immunotherapy Response in mTNBC Using cfDNA-Based Copy-Number Profiling
Tracking Lineage Infidelity in Pediatric B-ALL: New Insights From ASH
Kathrin M. Bernt, MD
Rushabh Mehta, BS
Fatemeh Alikarami
Beyond the Cure: Addressing Psychosocial Needs in Gene Therapy for SCD
Victoria Coleman-Cowger, PhD
Predicting Prognosis in DLBCL: The Role of Immune-Related Gene Signatures
Early Liquid Biopsy in Advanced Lung Cancer: Real-World Data Suggest Targeted Gains
Expanding the Risk Profile: Genetic Insights Into Lung Cancer in Non-Smokers
Paola Marignani, PhD, EMBA
Unlocking Tumor Complexity: Single-Cell RNA Sequencing in Lung Cancer
Targeting CCR4 in CAR-Associated Peripheral T-Cell Lymphoma
Mutational Complexity in ROS1-Positive mNSCLC: Insights from Real-World Practice
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.